Growth scare possibly unfolding ahead of Nvidia earnings, says Evercore ISI's Julian Emanuel
Julian Emanuel, Evercore ISI senior managing director, joins 'Fast Money' to talk the impact of tariffs, uncertainty, and ...
Evercore ISI Remains a Buy on Magnite (MGNI)
In a report released yesterday, Robert Coolbrith from Evercore ISI maintained a Buy rating on Magnite (MGNI – Research Report), with a price ...
Evercore ISI Keeps Their Buy Rating on Liberty Media Liberty Formula One (FWONK)
Evercore ISI analyst Kutgun Maral reiterated a Buy rating on Liberty Media Liberty Formula One (FWONK – Research Report) yesterday and set a ...
BioPharma Dive16h
Sanofi, Teva add to case for new bowel disease drug
Detailed results presented at a medical congress help reinforce analyst expectations the drug, called duvakitug, will be competitive with other Crohn’s, colitis medicines in testing.